Table 3.

Relative 1- and 5-year survival (% and 95%CI) in cancers of the oral cavity and pharynx in FI and SE women

FI women 1-y	1970–1979	1980–1989	1990–1999	2000–2009	2010–2019
Oral Cavity	70.5 [64.8–75.5]	73.9 [69.2–77.9]	83.6*[80.4–86.3]	82.9 [80.2–85.3]	84.8 [82.5–86.8]
Oropharynx	66.8 [54.9–76.2]	66.5 [56.1–74.9]	63.3 [52.1–72.6]	74.1 [64.4–81.6]	79.8 [74.5–84.1]
Nasopharynx	53.6 [38.7–66.4]	62.7 [48.3–74.1]	71.0 [55.5–81.9]	80.6 [56.8–92.1]	82.2 [61.4–92.4]
Hypopharynx	50.2 [39.6–59.9]	60.8 [47.9–71.4]	56.9 [42.3–69.1]	55.6 [39.3–69.2]	65.2 [49.1–77.3]
SE women 1-y	1970–1979	1980–1989	1990–1999	2000–2009	2010–2019
Oral Cavity	76.4 [73.2–79.3]	77.6 [74.7–80.3]	79.3 [76.7–81.7]	81.3 [79.0–83.4]	86.5*[84.6–88.1]
Oropharynx	66.7 [59.1–73.2]	72.2 [65.8–77.6]	74.9 [69.8–79.3]	76.7 [72.1–80.6]	86.2*[83.2–88.6]
Nasopharynx	58.8 [50.8–65.9]	66.5 [57.4–74.0]	80.5 [69.6–87.9]	76.4 [64.1–84.9]	92.0*[79.0–97.1]
Hypopharynx	46.2 [38.5–53.5]	50.5 [41.7–58.7]	50.5 [41.1–59.2]	57.7 [48.3–65.9]	61.3 [52.1–69.3]
FI women 5-y	1970–1979	1980–1989	1990–1999	2000–2009	2010–2019
Oral Cavity	46.4 [39.7–52.8]	53.9 [48.2–59.3]	63.4 [58.8–67.7]	68.3 [64.5–71.8]	73.3 [69.6–76.6]
Oropharynx	38.3 [26.2–50.2]	44.9 [34.0–55.2]	41.1 [29.4–52.4]	52.2 [40.5–62.6]	62.6 [55.4–68.9]
Nasopharynx	29.9 [17.5–43.3]	35.8 [22.8–49.0]	53.8 [37.2–67.8]	46.1 [24.4–65.3]	75.1 [54.4–87.4]
Hypopharynx	12.6 [6.5–20.7]	18.5 [9.5–29.9]	20.3 [10.2–32.8]	21.5 [10.0–35.8]	30.3 [15.1–47.0]
SE women 5-y	1970–1979	1980–1989	1990–1999	2000–2009	2010–2019
Oral Cavity	55.6 [51.3–59.7]	52.4 [48.6–56.1]	58.2 [54.7–61.6]	62.2 [59.0–65.2]	68.7*[65.6–71.7]
Oropharynx	44.5 [35.9–52.7]	39.4 [32.5–46.2]	52.4*[46.3–58.1]	55.0 [49.5–60.1]	69.9*[65.1–74.2]
Nasopharynx	34.4 [26.4–42.5]	47.1 [37.3–56.3]	50.1 [38.0–61.0]	51.7 [37.0–64.6]	67.2 [48.7–80.2]
Hypopharynx	17.6 [11.8–24.3]	13.8 [8.4–20.6]	26.9 [18.6–35.9]	27.6 [19.6–36.2]	34.7 [25.0–44.6]

Bolding: Survival significantly increased between last and first period. ^*Survival significantly increased between the periods